Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Hadassah Researchers Use Functional MRI to Detect Responsiveness in Unconscious Patients

"The clinical evaluation of consciousness in Disorder of Consciousness (DOC) patients, based on their exhibited behavior, is difficult and remains erroneous in many cases," report researchers at the Hadassah Medical Organization.

Aiming to determine the plausibility and challenges of implementing a clinical service to evaluate the consciousness level in patients suffering from (DOC), the researchers found via Functional MRI that different patients exhibited different degrees of responsiveness. They explain that recent studies demonstrate different levels of stimulus processing, as well as evidence of some level of awareness in sub-groups of these patients.

With 500 beds, 19 stories (five underground) and state-of-the-art technical equipment, the Tower is the most advanced medical facility in the Middle East.

DONATE

Join

Advocate

Lead

LEARN MORE

View all of our Impact Areas

The study was composed of 11 patients (ages 11-67), who were diagnosed as being in either vegetative or minimally conscious states. Using Functional MRI, researchers evaluated auditory, language, voice familiarity, imagery, and visual responsiveness.

The authors report: In 9 patients, they found auditory-related activation; however, only in 5 of the subjects was differential activation found for language. Six patients exhibited differential response to their own name. In three patients, a response to visual stimuli was identified. In one patient, the auditory and linguistic systems were clearly activated in a hierarchical pattern and, moreover, willful modulation of brain activity was identified in the imagery test.

Lead Author of the study was Atira S. Bick, coordinator of the clinical service in Hadassah's Functional MRI Unit. The original research article, entitled "Implementing Novel Imaging Methods for Improved Diagnosis of Disorder of Consciousness Patients", appears in the Journal of the Neurological Sciences, Volume 334, Issues 1–2, 15 November 2013, Pages 130-138.

Date: 1/14/2014

Hadassah's Hospitals: Employing, Treating, Training Palestinians and Israelis Side by Side

Terror Attack Survivor Gives Birth to Baby Boy at Hadassah's Hospital

Hadassah Surgeon Ahmed Eid Performs Life-Saving Surgery on Jerusalem Terror Victim

Israeli Hero Treated at Hadassah's Hospital on Mount Scopus

Profile of a Hadassah Hero: Dr. David Rekhtman

Palestinian Pediatric Patient Has Good Prognosis Following Liver Surgery at Hadassah

Wounded Paratrooper Prepares to Return Home from Hadassah

Romanian Medical Student Thanks Hadassah for Giving Him His Life Back

Shahar: Dawn of a New Healthy Life, Thanks to Hadassah’s Oncology Team

When it Comes to Heart Attacks, Hadassah Protocol Saves Lives

World-Renowned Mathematician, Near Death, Saved at Hadassah’s Trauma Unit

Her Excellency Marie Bashir Sees Bridges to Peace at Hadassah's Hospitals

Hadassah Researcher Honored with Prestigious Prize for Blood Discovery

IVF Babies: A Gift of Israel and Hadassah to Its People

Healing Garden at Hadassah's Hospitals Dedicated to Smorgon Family

International Symposium on Pancreatic Disease Headed Up by Hadassah Specialist

BioLineRx to Commence Phase 1 Stem Cell Trial at Hadassah Medical Organization

Hadassah’s Prof. Eitan Kerem Receives European Cystic Fibrosis Society 2014 Prize

Hadassah's School Awarded 2014 National Education Award

International “No Smoking Day 2014” at Hadassah's Hospitals



More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America